Guideline on Virus Safety Evaluation of Biotechnological Investigational Medicinal Products

July 10, 2006

London, 07 Jul 2006

Full text

[...]

EXECUTIVE SUMMARY

The purpose of this document is to provide scientific guidance relating to the viral safety of biotechnological medicinal products used in clinical trials. Guidance is provided with respect to:

  • the criteria for and the extent of viral safety evaluation studies, especially validation studies, that are required prior to and during clinical development.

  • the extent to which manufacturers are able to refer to in-house experience concerning virus safety evaluation.

  • the risk assessment which should form part of the safety evaluation.

    [...]

    Full text

    European Agency for the Evaluation of Medicinal Products - EMEA

    • Register to continue

    Why register?

    • Registration is free and only takes a moment
    • Once registered, you can read 3 articles a month
    • Sign up for our newsletter
    Register
    Please Login or Register to read this article.

    Sponsored

    Featured jobs

    See all jobs